• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    SANUWAVE Health To Organize Shock Wave Scientific Program

    Bryan Mc Govern
    May. 24, 2017 08:18AM PST
    Biotech Investing

    SANUWAVE Health announced Medical Advanced Technologies is sponsoring a one-day scientific program to take place in Italy.

    SANUWAVE Health (OTCQB:SNWV) announced Medical Advanced Technologies is sponsoring a one-day scientific program to take place in Italy.
    As quoted in the press release:

    MATEK has been one of SANUWAVE’s most active partners in promoting both dermaPACE® and orthoPACE® in Europe. Their innovative and proactive approach towards promoting dermaPACE and orthoPACE is reflected in this program which will assemble some of the most accomplished medical researchers and medical practitioners in Italy. The program will discuss the newest clinical information related to the mechanism of action for SANUWAVE’s product line and to discuss clinical case-studies and on-going research in the field of extracorporeal shock wave technology (ESWT) and in particular the use of dermaPACE for wound indications and orthoPACE for orthopedic indications. Specific topics include:

    • Update on mechanism of action: from mechanobiology to the clinical practice, M.C., D’Agostino
    • Shock Wave Therapy for Myofascial Syndrome “Trigger Point”, A. Previtera
    • Update about international guidelines and new therapeutic frontiers, E. Tibalt

    Click here to read the full press release.

    Source: www.marketwired.com

    europe
    The Conversation (0)

    Go Deeper

    AI Powered
    Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

    Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

    beyond medical

    Beyond Medical Technologies

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES